Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7391 | 1372 | 32.9 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
59 | 3 | ANESTHESIOLOGY//PAIN//CHRONIC PAIN | 88506 |
2479 | 2 | BREAKTHROUGH PAIN//CANCER PAIN//FENTANYL | 3954 |
7391 | 1 | MORPHINE 6 GLUCURONIDE//OXYCODONE//MORPHINE 3 GLUCURONIDE | 1372 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MORPHINE 6 GLUCURONIDE | authKW | 1130423 | 6% | 58% | 87 |
2 | OXYCODONE | authKW | 1046981 | 11% | 31% | 154 |
3 | MORPHINE 3 GLUCURONIDE | authKW | 833230 | 5% | 59% | 63 |
4 | HYDROMORPHONE | authKW | 374156 | 4% | 29% | 59 |
5 | OXYMORPHONE | authKW | 245705 | 2% | 39% | 28 |
6 | MORPHINE | authKW | 209905 | 19% | 4% | 260 |
7 | NOROXYCODONE | authKW | 202311 | 1% | 91% | 10 |
8 | MORPHINE METABOLITES | authKW | 188041 | 1% | 65% | 13 |
9 | MORPHINE 6 GLUCURONIDE M6G | authKW | 155781 | 1% | 100% | 7 |
10 | CONTROLLED RELEASE MORPHINE | authKW | 133527 | 0% | 100% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Anesthesiology | 11805 | 18% | 0% | 244 |
2 | Pharmacology & Pharmacy | 7960 | 45% | 0% | 614 |
3 | Health Care Sciences & Services | 1617 | 8% | 0% | 106 |
4 | Medicine, General & Internal | 733 | 12% | 0% | 166 |
5 | Clinical Neurology | 715 | 11% | 0% | 155 |
6 | Toxicology | 564 | 7% | 0% | 93 |
7 | Neurosciences | 177 | 9% | 0% | 126 |
8 | Medicine, Legal | 175 | 1% | 0% | 18 |
9 | Chemistry, Medicinal | 172 | 4% | 0% | 56 |
10 | Medicine, Research & Experimental | 81 | 4% | 0% | 56 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LOTUS CLIN LLC | 66763 | 0% | 100% | 3 |
2 | CHRON PAIN DAY PROGRAM | 50071 | 0% | 75% | 3 |
3 | PROGRAM CENTURY 21SURUGA KU | 44509 | 0% | 100% | 2 |
4 | GREY NUNS COMMUNITY HOSP HLTH | 33379 | 0% | 50% | 3 |
5 | STOCKHOLMS SJUKHEM FDN | 33379 | 0% | 50% | 3 |
6 | ANESTHESIOL INTENS CARE EMERGENCY CARE PAI | 22880 | 0% | 17% | 6 |
7 | ABT ALLGEMEINE INNERE MED ALTERSMED | 22254 | 0% | 100% | 1 |
8 | ABT PALLIAT MED MERZTHER IE | 22254 | 0% | 100% | 1 |
9 | ACUTE PAIN CARE SERV | 22254 | 0% | 100% | 1 |
10 | AFFILIATED CANE HOSP | 22254 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN PAIN RESEARCH AND THERAPY | 25741 | 2% | 4% | 27 |
2 | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 20066 | 4% | 2% | 55 |
3 | JOURNAL OF ANALYTICAL TOXICOLOGY | 6377 | 2% | 1% | 31 |
4 | PHARMACOLOGY & TOXICOLOGY | 4960 | 2% | 1% | 23 |
5 | PAIN | 4727 | 3% | 1% | 41 |
6 | CLINICAL ONCOLOGY MONOGRAPHS | 4082 | 0% | 6% | 3 |
7 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 3866 | 2% | 1% | 32 |
8 | PALLIATIVE MEDICINE | 3639 | 1% | 1% | 16 |
9 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3310 | 3% | 0% | 35 |
10 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2979 | 2% | 0% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MORPHINE 6 GLUCURONIDE | 1130423 | 6% | 58% | 87 | Search MORPHINE+6+GLUCURONIDE | Search MORPHINE+6+GLUCURONIDE |
2 | OXYCODONE | 1046981 | 11% | 31% | 154 | Search OXYCODONE | Search OXYCODONE |
3 | MORPHINE 3 GLUCURONIDE | 833230 | 5% | 59% | 63 | Search MORPHINE+3+GLUCURONIDE | Search MORPHINE+3+GLUCURONIDE |
4 | HYDROMORPHONE | 374156 | 4% | 29% | 59 | Search HYDROMORPHONE | Search HYDROMORPHONE |
5 | OXYMORPHONE | 245705 | 2% | 39% | 28 | Search OXYMORPHONE | Search OXYMORPHONE |
6 | MORPHINE | 209905 | 19% | 4% | 260 | Search MORPHINE | Search MORPHINE |
7 | NOROXYCODONE | 202311 | 1% | 91% | 10 | Search NOROXYCODONE | Search NOROXYCODONE |
8 | MORPHINE METABOLITES | 188041 | 1% | 65% | 13 | Search MORPHINE+METABOLITES | Search MORPHINE+METABOLITES |
9 | MORPHINE 6 GLUCURONIDE M6G | 155781 | 1% | 100% | 7 | Search MORPHINE+6+GLUCURONIDE+M6G | Search MORPHINE+6+GLUCURONIDE+M6G |
10 | CONTROLLED RELEASE MORPHINE | 133527 | 0% | 100% | 6 | Search CONTROLLED+RELEASE+MORPHINE | Search CONTROLLED+RELEASE+MORPHINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANDERSEN, G , CHRISTRUP, L , SJOGREN, P , (2003) RELATIONSHIPS AMONG MORPHINE METABOLISM, PAIN AND SIDE EFFECTS DURING LONG-TERM TREATMENT: AN UPDATE.JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. VOL. 25. ISSUE 1. P. 74-91 | 99 | 88% | 52 |
2 | KILPATRICK, GJ , SMITH, TW , (2005) MORPHINE-6-GLUCURONIDE: ACTIONS AND MECHANISMS.MEDICINAL RESEARCH REVIEWS. VOL. 25. ISSUE 5. P. 521-544 | 99 | 61% | 74 |
3 | KLIMAS, R , MIKUS, G , (2014) MORPHINE-6-GLUCURONIDE IS RESPONSIBLE FOR THE ANALGESIC EFFECT AFTER MORPHINE ADMINISTRATION: A QUANTITATIVE REVIEW OF MORPHINE, MORPHINE-6-GLUCURONIDE, AND MORPHINE-3-GLUCURONIDE.BRITISH JOURNAL OF ANAESTHESIA. VOL. 113. ISSUE 6. P. 935 -944 | 56 | 82% | 12 |
4 | KING, S , FORBES, K , HANKS, GW , FERRO, CJ , CHAMBERS, EJ , (2011) A SYSTEMATIC REVIEW OF THE USE OF OPIOID MEDICATION FOR THOSE WITH MODERATE TO SEVERE CANCER PAIN AND RENAL IMPAIRMENT: A EUROPEAN PALLIATIVE CARE RESEARCH COLLABORATIVE OPIOID GUIDELINES PROJECT.PALLIATIVE MEDICINE. VOL. 25. ISSUE 5. P. 525 -552 | 79 | 56% | 45 |
5 | LOTSCH, J , GEISSLINGER, G , (2001) MORPHINE-6-GLUCURONIDE - AN ANALGESIC OF THE FUTURE?.CLINICAL PHARMACOKINETICS. VOL. 40. ISSUE 7. P. 485-499 | 83 | 74% | 63 |
6 | KLIMAS, R , WITTICKE, D , EL FALLAH, S , MIKUS, G , (2013) CONTRIBUTION OF OXYCODONE AND ITS METABOLITES TO THE OVERALL ANALGESIC EFFECT AFTER OXYCODONE ADMINISTRATION.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 9. ISSUE 5. P. 517-528 | 45 | 87% | 12 |
7 | MILNE, RW , NATION, RL , SOMOGYI, AA , (1996) THE DISPOSITION OF MORPHINE AND ITS 3- AND 6-GLUCURONIDE METABOLITES IN HUMANS AND ANIMALS, AND THE IMPORTANCE OF THE METABOLITES TO THE PHARMACOLOGICAL EFFECTS OF MORPHINE.DRUG METABOLISM REVIEWS. VOL. 28. ISSUE 3. P. 345-472 | 129 | 43% | 133 |
8 | LEPPERT, W , (2010) ROLE OF OXYCODONE AND OXYCODONE/NALOXONE IN CANCER PAIN MANAGEMENT.PHARMACOLOGICAL REPORTS. VOL. 62. ISSUE 4. P. 578 -591 | 55 | 69% | 16 |
9 | OLKKOLA, KT , KONTINEN, VK , SAARI, TI , KALSO, EA , (2013) DOES THE PHARMACOLOGY OF OXYCODONE JUSTIFY ITS INCREASING USE AS AN ANALGESIC?.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 34. ISSUE 4. P. 206-214 | 51 | 66% | 12 |
10 | SMITH, MT , SOUTH, SM , (2001) THE ROLE OF MORPHINE-6-GLUCURONIDE (M6G) IN PAIN CONTROL.PAIN REVIEWS. VOL. 8. ISSUE 3-4. P. 171 -191 | 74 | 68% | 1 |
Classes with closest relation at Level 1 |